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Abstract 
Cadmium selenide (CdSe) nanoparticles (NPs) have applications in biomedical, 
biochemistry, bioimaging areas through different methods such as cell labelling and drug 
delivery (Chapter1). This study aims to test the optical and biological properties of CdSe 
NPs so that its applications can be improved in these areas in the future.  
Three types of CdSe NPs have been synthesised using a wet chemical method with the 
molar ratio of Cd:Se 10:1, 4:1 and 1:1. The observed luminescence of the CdSe NPs was 
strong and stable. The maxima PL spectrum peak of the CdSe (10:1) nanoparticles was 
around 590 nm and the ultraviolet-visible absorption (UV-Vis) spectrum showed a peak 
between 530-550 nm. The photoluminescence peak of CdSe (4:1) was the same as CdSe 
(10:1) and the UV-Vis spectrum showed a peak at about 550 nm. The aging studies 
indicate that sodium citrate (a stabiliser) could enhance the stability of the CdSe NPs. For 
example, the CdSe NPs with 0.2% sodium citrate were more stable than 0.05% (Chapter 
3). Using this property, more stable encapsulated drugs could be made in the future to 
improve the clinical treatment method (Chapter 1).  
Cell toxicity of the CdSe NPs was evaluated through the use of 3-(4, 
5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The MTT results 
show that the more Cadmium ions accumulated in HHL-5 cells, the greater the cell 
toxicity is. The results (keeping the cadmium level constant) also indicate that CdSe NPs 
with a cadmium to selenite ratio with 10:1 (CdSe (10:1) had the strongest toxicity in 
HHL-5 cell of all these three kinds of CdSe NPs tested. Conversely, the CdSe (1:1) has 
the lowest toxicity among all. The results indicated that the toxicity of the cadmium were 
very obvious so that we need to avoid accumulation of cadmium in clinical. In addition, 
the confocal images in MCF-7 cells also reflect the relative toxicities of the CdSe NPs. 
The results of the confocal images indicated that the higher concentrations of the CdSe 
NPs in the cells, the greater the observed toxicity is.  
Moreover, all the experiments in this study (aging, TEM, quantum yield, MTT, confocal) 
are surrounding 9 kinds of CdSe NPs without any other parameters, which are novel and 
unique. 
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Chapter 1. Introduction and general background 
1.1 Nanoparticles and their applications 
Over the past century, scientists have made many great voyages of discovery. In 1959 
Richard Feynman said that ‘There’s Plenty of Room at the Bottom’, which indicated the 
potential in atomic and molecular scales, and in nanotechnology.
1
  Nanotechnology, 
nanoparticle (NPs), can be defined as the manipulation of matter with at least one 
dimension in the nanoscale 1 to 100 nanometers, as defined by National Nanotechnology 
Initiative.
1
 Because of this size range, nanotechnology has a diverse range of applications 
in many fields, such as energy, surface science, organic chemistry, molecular biology, 
medical technologies and semiconductor physics.
2, 3
 
In nanotechnology, a particle is defined as a small object that behaves as a whole unit 
with respect to its transport and properties.
4
 Nanoparticles can be made by a wide variety 
of materials, including metals, semiconductors, organic materials or biomaterials. All 
these materials can be incorporated into nanomaterials. As defined above, a nanomaterial 
is a material with at least one external dimension in the nanoscale (1–100 nm); whereas a 
nanoparticle is defined as a material with all three external dimensions in the nanoscale.
6
  
In some materials, when the particle size is reduced, a phenomenon called quantum 
confinement can be observed. Quantum confinement is the effect which can be observed 
for some nanomaterials/nanoparticles. When the particles size is similar or smaller than 
the exciton size this phenomenon will happen and it usually happens in a few 
nanometers.
1
 Quantum confinement effect is the idea behind the “Particle in Box” model; 
it indicates that once the diameter of the material is of the same magnitude as the 
wavelength of the electron wave function. When materials are this small (which means 
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the particle size is similar or smaller than the exciton size, usually happens in a few 
nanometers), their electronic and optical properties deviate substantially from those of 
bulk materials.
1
 This means that an electron cannot move freely as it in the buck material 
so that it’s optical and electronically properties will be changed. The energy levels can 
then be modeled using the particle in a box model in which the energy of different states 
is dependent on the length of the box.
1
 The particle in the box model could be explained 
by the difference between classical and quantum systems. In classical systems, a ball 
stuck inside a big box so that the particle can move with any speed in the box and it is no 
more likely to be found at one position than another.
1
 By classical mechanics we could 
roll a particle along the x-axis in this box and predict its position at any later time (Figure 
1.1, equation 1.1).
1
 The potential energy in this model is given as 
 
Figure 1.1 particle in the box 
                       Equation 1.1 
Where L is the length of the box and x is the position of the particle within the box. The 
electron moves between two walls at x=0 and x=L.
1 
The potential energy of the particle is 
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zero between the walls and infinity at the walls. What this statement is saying is that the 
particle can only be between x=0 and x=L.
1
  
However, when the well becomes narrow (usually happens in a few nanometres), the 
particle could only occupy certain positive energy levels.
1
 This means that the observable 
properties of the particle (such as its energy and position) are related to the mass of the 
particle and the width of the well.
1
 In quantum mechanics, the wavefunction gives the 
most fundamental description of the behaviour of a particle; the measurable properties of 
the particle (such as its position, momentum and energy) may all be derived from the 
wavefunction.
1 
For a particle inside the box a free particle wavefunction is appropriate, 
but since the probability of finding the particle outside the box is zero, the wavefunction 
must go to zero at the walls (which means V=0, equation 1.3).
1
 The behaviour of a 
particle is completely specified quantum mechanically by the Schrödinger equation is 
given as: 
                              Equation 1.2 
Where  is the Hamiltonian that describes the system, and  and E are eigenfunctions 
and eigenvalues.
1
 When the Hamiltonian operator acts on a certain wave function Ψ, and 
the result is proportional to the same wave function Ψ, then Ψ is a stationary state, and the 
proportionality constant, E, is the energy of the state Ψ.1 For any particle, the total energy of 
that particle is the sum of the kinetic and potential energy.
1
        
                  Equation 1.3 
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Where h is Planck's constant, m is the mass of the particle (an electron in this case), and V 
is the potential energy.
1
 In summary, the quantum confinement effect theory explains why 
nanomaterial such as Ag nanoparticles will lose electric and heat conduction 
characteristics and become semiconductor.  
Semiconductors have become a major interdisciplinary area of science. A semiconductor 
is a material which has an electrical conductivity between that of a conductor (for 
instance, copper) and insulator (such as glass).
9, 10
 The conductivity of a semiconductor 
will change with increasing temperature and shows opposite electrical conductivity 
characteristics to that of metal.
9
 This characteristic of semiconductors can be useful in a 
number of applications, for example in the fabrication of thin-film organic electronic 
devices. 
11, 12
 
1.1.1 Optical characteristics of Nanoparticles and their applications 
A characteristic of semiconductor nanoparticles is optical fluorescence. Fluorescence is 
the emission of light by a substance that has absorbed light or other electromagnetic 
radiation and is a form of luminescence.
13
 Photoluminescence (PL) describes the 
phenomenon of light emission from any form of matter after the absorption of photons 
(electromagnetic radiation) and is one of a number of forms of luminescence.
14
 According 
to the quantum size effect theory, when the size of a particle becomes extremely small, 
and the electronic wave function is confined, quantum-size effects (QSE) are expected to 
occur. When this happens, changes in the density of states, the transport properties and 
the optical properties that differ from the bulk material can be observed.
15
 Many optical 
techniques can be used to measure these characteristics of nanoparticles. Nanoparticles 
composed of different materials will have unique emission wavelengths, excitation 
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wavelengths and hence varied emission colours. A number of techniques use absorbance, 
emission or reflectance of light to obtain spectra to help characterize this optical 
properties.
16-24 
With the help of Transmission electron microscopy (TEM) and Scanning electron 
microscopy (SEM), the size and the outline of individual nanoparticles can be measured 
and seen directly and clearly under the microscope. Due to the booming development of 
nanotechnology, the original TEM technology has been upgraded to Super STEM. Super 
STEM can even capture vivid single atom images, a dramatic improvement in image 
quality of nanoparticles.
20, 22, 24-27
 
1.1.2 Nanotoxicity and applications 
In addition to the properties of nanoparticles discussed above, they can also display 
toxicity, also known as nanotoxicity. Nanotoxicology is the study of the toxicity of 
nanomaterials. With the rapid development of nanotechnology, the understanding of the 
nanotoxicity of nanomaterials and nano-enabled products has become more and more 
important in terms of both human and environmental health and safety. This concept is 
widely accepted by not only scientists but also by the public.
30
 As a result the whole area 
of toxicity of nanoparticles has been and is still actively investigated.
31
 
Due to their exciting electrical, optical and physical properties, nanoparticles have a wide 
range of applications in drug delivery, cancer treatment, diagnostics, photothermal 
therapy, bioimaging, biosensing, tissue engineering and bioterrorism prevention.
32, 33
 In 
particular; nanoparticles have a unique advantage in clinical studies due to their size and 
properties. For example, polymer nanoparticles can be used to encapsulate drugs so that 
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they can cure and prevent cancer. The tumor microenvironment is a special challenge for 
drug delivery. In the past, it has been difficult to target the specific tumor cells while 
ensuring minimal systemic toxicity at the same time.  Additionally, due to the lack of 
specificity, sometimes the drug will damage the healthy cells which surround the tumor 
cells. However, with the help of nanoscale carriers, it is possible to overcome both 
systemic and tumor barriers and provide specific and targeted delivery.
34
 
Nanoparticles can be incorporated and incubated with drugs easily within micelles until 
they are released into the target cells. They also have the ability to stabilize the drugs for a 
long-term exposure. In this way, nanomedicine can be defined as the primary application 
of nanotechnology in health.
35
 
Overall, these significant and unique characteristics of nanoparticles have resulted in their 
great popularity. With the help of nanoparticles, many fields in our life have been 
improved. However, everything has two sides. Indeed, the benefits of the nanoparticles 
are huge, but their disadvantages such as pollution, the inhalation of particles
36 
and 
nanotoxicity due to accumulated NPs in organs, are issues we need to pay attention to.  
1.2 Quantum dots and their applications 
Another spectacular development in the microworld was the quantum revolution.
37
 In 
1980, Alexei Ekimov, a Russian solid state physicist discovered semiconductor 
nanocrystals also known as quantum dots (QDs) or colloidal semiconductor 
nanocrystals.
28, 38
 
Quantum dots (QDs) are nanometer-scale semiconductor crystals defined as particles with 
physical dimensions smaller than the exciton Bohr radius of the material.
39,40
 Quantum 
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dots are semiconductor nanocrystals usually ranging from 2-10 nanometers or more than 
50 atoms
1 
and they are composed of a hundred to a thousand atoms. These semiconductor 
materials can be made from an element, such as silicon or germanium, or a compound, 
such as CdS or CdSe. These small sized particles behave differently and can show some 
difference in colour, size, and electrical, nonlinear or optical properties when compared to 
the bulk material. These unique properties of nano sized particles are partly the result of 
the unusually high surface to volume ratios. These unusual characteristics give quantum 
dots an unprecedented number of potential applications in all kinds of areas in our life, 
such as biomedical imaging, electronics, biosensors and many other fields.
1, 41
 
1.2.1 Optical properties of Quantum dots and their applications 
The unique optical and electronic properties can give quantum dots some of the benefits 
over other materials, such as organic dyes, fluorescent proteins and lanthanide chelates.
39, 
42
 Most notably, some characteristics which have a significant influence on both 
fluorophore behavior and applications of quantum dots such as the width of excitation and 
emission spectra, , photostability and fluorescence lifetime.
39
 
When compared to conventional narrow dyes, QDs have broad absorption and emission 
spectra which can provide the possibility for excitation of different colours 
simultaneously.
43
 Quantum dots can emit photons if excited, the smaller the dot, the 
higher the energy of the emitted light.
43
 By using different excitation and emission 
wavelengths, the full spectrum of colours would be available; this property can be widely 
used in large screen televisions and cell phones. Based on this quantum electrical 
characteristic, the electronics industry has been inspired, to use this property. For example, 
it is possible to make light-emitting diodes (LEDs) and backlights of computers using 
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quantum dots. Similarly, quantum dots could also be used in solar cells, not only 
providing a higher quality and efficiency of power generation but also reducing the 
consumption of non-renewable power sources.
44
 
Luminescent semiconductor quantum dots also are being used as a new fluorescent 
labeling method for use in cell imaging.
45
 They can also be used as probes in transmission 
electron microscopy (TEM), energy-filtered TEM (EFTEM) and scanning electron 
microscopy (SEM). A simple way is to use the QDs as TEM tags is to label a nuclear 
protein on cell sections, allowing fluorescence images to be obtained.
45
 Additionally, the 
quantum dot probes can also be used in conjunction with immune gold for co-localization 
of proteins at an ultra-structural level. Further research also shows the potential of QDs 
together with EFTEM for co-localization of variety of different kinds of proteins.
45
 
Photosability is a significant element in most fluorescence applications and give quantum 
dots an overwhelming advantage over other florophores. Quantum dots, as fluorescent 
probes coated with a suitable chemical shell, can improve the water stability; can enhance 
the strength of fluorescence, the photostability and other properties of the original QDs, 
so that these new QDs can work better in the target cells or areas. For example, coating 
ZnO quantum dots with silica can improve their water stability.
46
 Moreover, graphene 
quantum dots (GQDs) have a high photostability which can significantly improve the 
problems such as photobleaching, blinking, low biocompatibility and high toxicity.
47
 
Furthermore, the new GQDs have improved properties such as, less negative surface 
charges so that they are less easily digested by cells, have lower toxicity, and improved 
photoluminescence.
47
 Last but not least, quantum dots can undergo repeated excitation 
and still keep a bright fluorescence for hours without any decay of intensity.
39, 43, 48
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1.2.2 Cytotoxicity of Quantum dots and their application 
The cytotoxicity of QDs, has an important influence on cell growth and cell viability, and 
has been observed in numerous in vitro studies.
39, 53-59
 Many factors can affect the toxicity 
of QDs including their size, capping materials, surface chemistry, coatings, bioactivity 
and changes to these factors during processing.
1, 39, 59, 60
 Moreover, with the help of 
quantum dots, the quality of the results by existing techniques can be improved as well 
such as the confocal microscopy.
39, 57, 61, 62
 
There are many mechanisms which contribute to the cytotoxicity QDs such as the release 
of toxic free ions and the generation of free radicals. Using different chemical coatings, 
such as a ZnS shell, of QDs with Cd as a core has been observed to dramatically reduce 
rates of oxidation and the leakage of Cd ions.
39, 63, 64
 
Because of the numerous types and properties of QDs, they have a wide range of 
biomedical and biological-applications. QDs encapsulated in special micelles can be used 
to label individual cells. These encapsulated QDs show stable and nontoxic properties 
before they adhere to the target cells. With the fluorescence and different colours of the 
encapsulated QDs, the target cells will be easy to track.
39 
By doing so, no matter where 
the target cells go, it can still be found and/or eliminated. 
 In particular, in clinical applications, if tumor cells are labeled with QDs, it can be easy 
to detect the degree of aggression and the location of the tumor cells so that they can be 
eliminated.
65
 In this way, it will significantly improve the efficiency and accuracy of the 
doses and decrease the consumption of the drug. Therefore, QDs have potential in 
anticancer therapy and have an inestimable potential in biomedicine and clinical 
applications in the future.  
10 
 
The effects of quantum dots are not only important in cell tracking where they have 
already been shown to have an overwhelming advantage over conventional fluorophores 
due to long fluorescence lifetime and strong photostability but also in in vivo animal 
imaging.  
New kinds of QDs (Type II QDs), which use CdTe as a core and CdSe as the shell, can 
label normal tissues as well as tumour cells. Bioluminescent QDs, which can be absorbed 
by the digestive system and bring no harm to liver still need to be discovered. Therefore, 
there are still lots of animal experiments needed to be done before QDs can be used in 
human body.  
In conclusion, some excellent properties of QDs have been discovered and applied in 
many areas of our lives. More and more people have an awareness of the benefits of QDs. 
But the disadvantages still need to be considered.  
1.3 Cadmium selenide nanoparticles and their applications 
Cadmium selenide, as an inorganic compound with the formula CdSe, and is a 
yellow-orange solid which belongs to a Ⅱ-Ⅵsemiconductor of the n-type (extrinsic 
semiconductor with a larger electron concentration than hole concentration).
68, 69
 CdSe 
particles usually less than 10 nm.
20, 22, 24-27
 After the size has been reduced, the CdSe NPs 
exhibit unique properties that are totally different from the bulk material. This is because 
of the quantum confinement effect where the size of the particle becomes smaller than the 
size of the exciton responsible for light emission.
7, 8
 This property of CdSe NPs produces 
a range of different flouresence depending on the size of the particle.
70
 CdSeNPs are one 
of a number of semiconductor nanoparticles types that have attracted increased interest of 
11 
 
scientific community due to their low toxicity and their fluorescence and electronic 
properties.
5, 49, 54, 57, 58, 63, 71-78
 
There are many ways to synthesize CdSe NPs such as the micro emulsion method,
 79
 the 
hot injection method
70, 80,81
 the ultrasonic assisted ionic liquid method,
 82
 and the 
ultrasonic irradiation method.
83
 In this study due to the large variety of different kinds of 
CdSe NPs required, we choose a facile, inexpensive and less hazardous method which can 
ensure almost complete conversion of the precursors. This is a wet chemical method 
assisted by microwave-heating.
64, 84
 
These wet chemical methods are a group of methods used for producing nanoparticles and 
ultra-dispersed inorganic powders from aqueous and non-aqueous solutions. These use a 
liquid phase as one of the process stages.
85,86
 The uniqueness and advantage of this 
method is in the small grains produced and the low temperature and the short duration of 
the phase formation.
84
 Additionally, the equipment and chemicals required for the 
experiment can be easily found in a biology or chemistry laboratory. The process only 
requires items such as microwave oven machine, mechanical stirrers, and standard 
laboratory glassware and chemicals like Cadmium, selenite and sodium citrate can be 
stored in the laboratory with no inert atmosphere.  
There are two stabilizers which can be used to cooperate with particles. One is the ligand 
stabilizer and the other is the sodium citrate stabilizer. In this study, we synthesized the 
CdSe NPs with different amounts and levels of sodium citrate as stabilizer. The 
mechanism about how the sodium citrate could affect the particles is because the weakly 
coordinating trisodium citrate ligand which stabilizes nanoparticles through electrostatic 
interactions which is given as below
1
: 
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Figure 1.2 The electrostatic repulsion mechnism of sodium sictrate and CdSe NPs 
The negative sodium citrate ions are filled of the surface of the CdSe NPs which can 
attract the positive water ions so that the particles could be water soluble.
1
 Moreover, 
when each of this particle close to each other, they will repel because the same polar so 
that the particles will be separate easily.
1
   
1.3.1 Optical properties and applications of CdSe NPs 
There are different ways to synthesise different kinds of CdSe NPs, some of them are 
doped or covered with a chemical stabilizer such as sodium citrate 
64
 to maintain or 
improve the stability of the particles. Some studies covered the CdSe core with different 
kinds of chemical shell such as ZnS or surface capping layer.
21, 87
 Some of these studies 
use exterior elements such as light and heating temperature to change the properties of the 
CdSe NPs.
17, 20, 26, 88-90
 Indeed, all these methods can affect the optical properties of CdSe 
NPs and all these methods can have an effect on one or more of the followings four areas: 
photoluminescence, ultraviolet visible absorption, quantum yield result and the 
transmission electron microscopy images (visible particle size). 
-
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One study prepared CdSe NPs with G4.0-NH2 PAMAM dendrimers in water and tested 
how the metallic ions (Zn
2+
,
 
Cd
2+
) affected the photoluminescence (PL) properties of 
CdSe QDs by spectrophotometric titration. The results show that Zn
2+ 
and Cd
2+
ions can 
enhance the photoluminescence (PL) intensity of CdSe NPs because they can modify the 
surface of the particles. Cd
2+
 and Zn
2+
nanocomposites can emit bright yellow 
photoluminescence under ultraviolet excitation of 365 nm from an UV LED in the dark. 
This can be detected with a better resolving rate compared to the old method.
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Another study synthesized the CdSe NPs via a wet chemical method, using CdSe 
precursors mixed with hexadecylamine (HDA), tetradecylphosphine oxide (TDPO) and 
tri-n-octylphosphine oxide (TOPO) as complexion agents in tri-n-butylphosphine (TBP) 
solvent in the reactor with an argon atmosphere.
92
 By doing so, much larger sized CdSe 
NPs were produced, with enhanced stability and brighter photoluminescence (by 
adjusting synthesis temperature and reaction time)
92
 thus enhancing dramatically the 
potential of the these CdSe NPs in biomedical applications such as drug delivery.
92
 
A kind of bowknot-shaped structure formed from individual CdSe NPs which can be 
affected by ultraviolet (UV) light irradiation has been discovered recently.
93
 The 
structural transformation process happens due to the photo corrosion of CdSe NPs under 
UV light. This study indicates a new technique called photoetching. This technique can 
affect the transformation process and synthesis of nanoparticles. Therefore, the 
nanoparticles either irradiated or non-irradiated can be applied in photo electrochemical 
devices to verify the photovoltaic effect.
93
 
CdSe NPs synthesized in aqueous solutions with sodium citrate as a stabilizer display 
very low quantum yields initially without the influence of external elements such as light. 
14 
 
However, the quantum yield of CdSe NPs increases sharply under visible light. This leads 
to aqueous quantum dots with high luminescence that can be applied in biological and 
many other areas. This study found that the smooth surface of the CdSe core affects the 
luminescence of the CdSe NPs. If the CdSe core is shielded from photo corrosion, the 
luminescence of the CdSe NPs will be of greater intensity.
90
 
Microwave dielectric heating and irradiation can affect the size and other properties of 
CdSe NPs. This has been observed in many studies.
26, 27
 CdSe NPs fabricated with 
different cadmium complexes, such as Cd-Lu, Cd-Myr, Cd-St, Cd-ODPA and Cd-DDPA, 
under constant parameters which include temperature, ramp, hold, and cooling times lead 
to different TEM results.
27
 Even the same CdSe NPs prepared at different temperatures 
show drastic differences in their photoluminescence and TEM results. These results 
indicate that at higher temperature, larger particles are obtained and have higher quantum 
yields.
22
 Moreover, nanoparticles with a CdSe core and ZnS shell using 
tetranitro-methane (TNM) as an oxidant surface also lead to different shapes of TEM 
images.
25
 
Another novel method for the synthesis of CdSe QDs is using a CdSe/CdS core-shell 
structure with poly(acrylic acid) (PAA) as a capping ligand at 240°C. This can increase 
the quantum yields by up to 30% and the photoluminescence emission peak could be 
tuned from 530 to 600 nm by the size of CdSe core. These new CdSe QDs have many 
excellent properties such as good water solubility, and bright PL emission. These 
quantum dots can be used as a fluorescence labels for in vitro studies.
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One of the fundamental goals in biology is to understand the interplay between 
biomolecules from different cells. To observe these kinds of events, confocal microscopy 
15 
 
is necessary.
95
 Quantum dots like CdSe QDs can emit different colours when stimulated 
by visible light. Confocal microscopy can observe the fluorescence, colour, distribution 
and the outline of quantum dots. For example, confocal microscopy can be used to 
determine the distribution of QDs within polystyrene micro gel particles, dispersed in an 
organic solvent.
96
 Furthermore, the toxicity of nanoparticles such as CdSe NPs can also 
be tested by confocal microscopy. By adjusting the parameters of the confocal images and 
using different dye methods in the cells different materials will emit different colours so 
that they can be identified easily and clearly under the microscope. These properties of 
quantum dots have been exploited in biomedical applications.
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1.3.2 The cytotoxicity of CdSe NPs and their applications 
There are numerous ways to synthesize CdSe NPs to give different kinds of CdSe NPs. 
Some of them have different chemical layers; some of them are encapsulated within 
chemical shells.
98
 All these methods make a contribution to enrich the properties of CdSe 
NPs so that they can be applied in a wide range of areas including biology and 
biomedicine.   
The cytotoxicity and genotoxicity of QDs with a Cadmium selenide/Zinc sulfide 
(CdSe/ZnS) core/shell for applications in cancer therapy has been discussed recently. 
Human cancer cells which were treated with CdSe/ZnS QDs and UVB irradiation which 
lead to a lower cell viability rate and strong phototoxicity. The genotoxicity results 
indicated that UVB irradiation is the most effective method for increasing the potency of 
QDs during photodynamic cancer therapy.
98
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The cytotoxicity of different kinds of CdSe QDs variet in different cell lines and can be 
detected by different techniques. One of the most common techniques used to test for the 
toxicity in cells is the 3-(4, 5-dimethylthiazol)-2-diphenyltertrazolium bromide (MTT) 
assay. MTT is pale yellow in solution but produces a dark-blue formazan product with 
live cells. Besides the MTT assay, there are lots of assays which can test almost every 
property of the cells. For instance, the genotoxic effects toward cells can be reflected by 
DNA damage and can be examined by a comet assay.
99
 
The toxicity of Caco-2 cells treated by CdSe QDs with ZnS shell and poly-ethylene 
glycol (PEG) coating has been observed after 24 hours by a MTT assay. The results 
indicated that the cytotoxicity of CdSe QDs was modulated by surface coating. Initially, 
PEG coated CdSe QDs had less of an effect on Caco-2 cell viability and attachment. 
However, acid treatment can damage the surface coating and release Cd ions so that the 
toxicity of the CdSe QDs will be increased and the cell viability will be reduced sharply.
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There are many studies have already tested different properties of CdSe NPs so far; 
however, very a few of them discussed about the aging and toxicity properties in different 
ratios of Cadmium to Selenide NPs. This study focus on optical and biology properties of 
different ratios of Cd to Se NPs which can help us understand the CdSe NPs better, so 
that it would be very useful for the clinical research in the future. Overall, the optical 
properties and biology characteristics of CdSe NPs (QDs) can be applied in numerous 
areas, in particular in biology, bioimaging and biomedical areas.  
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Chapter 2. Experimental methods 
2.1 Synthesis of CdSe Nanoparticles by a microwave-assisted method 
The CdSe nanoparticles(CdSe NPs) were synthesized by the microwave heating of an 
aqueous solution of 0.01M cadmium perchlorate (CdCl2O8) as a source of cadmium ions 
with 0.01 M N, N-dimethyl Selenourea (C3H8N2Se) as a source of selenium ions, in the 
presence of 0.05, 0.1, 0.2%(w/v) sodium citrate (Na3C6H5O7) as a stabilizer.
1
 
Sodium citrate with a weight of 0.0284 gram was dissolved in 45 mL of deionised water, 
and the pH adjusted to 9.2 using 0.1M NaOH. Sodium citrate with a weight of 0.0568 
gram was dissolved in 45 mL of deionised water and the pH adjusted to 9.2 using 0.1M 
NaOH. Sodium citrate with a weight of 0.1136 gram was dissolved in 45 mL of deionised 
water and the pH adjusted to 9.2 using 0.1M NaOH. Cadmium perchlorate with the 
volume of 2mL and 2mL N, N-dimethyl Selenourea were added to the samples and the 
pH adjusted to 9.2 using 2M NaOH. Next, the mixture of precursors was heated in a 
conventional 800W microwave oven for 75 seconds and then stored in the dark at room 
temperature for 2-3 days to give the particles enough time to grow.
1-2
 
CdSe Quantum dots (CdSe QDs) were obtained by increasing the ratio of cadmium to 
selenium ions. This ratio was changed via the use of 2mL of 0.01, 0.04 and 0.1M 
cadmium perchlorate giving ratios of 1:1, 4:1 and 10:1 cadmium to selenium respectively. 
This resulted in average particle sizes of 5.0 nm, 5.8 nm, and 4.9 nm respectively 
(Chapter 3, Table 3.3). These measurements were made using transmission electron 
microscopy (TEM), with a sample size of 100 particles per measurement. 
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2.2 Photoluminescence spectroscopy 
Photoluminescence (PL) is a process in which a substance absorbs amd then re-radiates 
photons. This process involves the excitation of an electron to a higher energy state and 
then a return to a lower energy state accompanied by the emission of a photon (Figure 
2.2.1)
5
. 
 
Figure 2.1 Jablonski diagram. S0 is the the electronic state (ground sate). S1 is the 
electronic state (excited state) and number 0-5 are vibrational levels. 
The Jablonski diagram shows the sequence of the steps leading to fluorescence (Figure 
2.2.1). After the initial absorption, the upper vibrational states undergo radiation less 
decay; a process called vibrational relaxation.5 This energy is given up to the 
surroundings.
5
 A radiative transition then occurs from the excited state to the ground state 
(the heavy horizontal lines).
5
 Level spacing decreases as dissociation energy approached. 
The discrete energy usually become continuous at high enough energies because the 
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system can no longer exist as a bound state.
5
 The energy become more and more close 
when it approaches the dissociation energy.
5
 The energy levels after dissociation can take 
the continuous values with free particles.
5
 This energy separation is 10 to 100 times 
greater that of the vibrational levels.
5
 
The CdSe NPs samples were checked under a UV lamp and the colour of the 
luminescence was orange. According to the visible spectrum (Figure 2.2.2.a), the peak of 
the orange should be approximately 550 nm. Therefore, an excitation spectrum scan was 
taken at emission of 550 nm. The maximum peak in the graph was taken (about 345 nm) 
as the excitation wavelength of the samples (Figure 2.2.2.b). 
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Figure 2.2 a) Visible spectrum b) An excitation spectrum of the CdSe NPs samples 
Fluorescence emission spectra of CdSe NPs were recorded in a 10 × 10 mm quartz 
cuvette using a Perkin-Elmer LS55 spectrophotometer with the excitation wavelength set 
at 345 nm (Figure 2.2.3). The emission spectra were corrected using the solvent emission 
as background. 
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Figure 2.3 Diagram to explain how the spectrophotometer works. 
The ageing of the CdSe NPs samples was carried out to be test daily for first week and 
then once a week last for about three months to see if the curve and the peak of the 
spectrum changed with time. A pipette was used to transfer an appropriate volume of the 
CdSe NPs samples from the stock solution to the clean and empty cuvette. This was then 
covered with the lid. The chamber of the Perkin-Elmer LS55 spectrophotometer was 
opened and the cuvette was placed in it with the positive side (the side with label) towards 
the outside of the chamber. The software named FL winlab, was used to set the correct 
parameters. The emission range of the spectrum was between 300 to 800 nm. The 
excitation slit of the CdSe NPs samples was 15.0 nm and the emission slit was also 15.0 
nm. The scan speed of the samples was 600 nm per minute. The cuvette was cleaned with 
acetone and nanofiltered water. This process was repeated daily.  
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2.3 UV-Vis Spectroscopy 
Ultraviolet–visible spectroscopy (UV) or ultraviolet-visible spectrophotometry refers to 
absorption spectroscopy or reflectance spectroscopy in the ultraviolet-visible spectral 
region. Sample absorption spectra were recorded in a 10×10 mm quartz cuvette, and 
tested using a Perkin-Elmer 35 UV-Vis double-beam spectrophotometer. UV lab software 
was used to set the appropriate parameters. The scan range was between 200-800 nm with 
a 600 nm/min rate. A blank (the solvent of the sample) was scanned, the cuvette was then 
washed with acetone and nanofiltered water, a sample from the stock solution was added 
to the cuvette and a spectrum was taken.  
2.4 Quantum Yield Measurement 
The quantum yield (QY) is the ratio of emission photons over the total number of photons 
absorbed by the sample. The most reliable method for recording QY is the comparative 
method documented by Williams,
 6
 which use standard samples with known QY values. 
This method compares the integrated fluorescence intensity and the absorption for an 
unknown sample and standard at absorbance between 0.1 and 0.01.  
Basically, a quinine reference which the quantum yield rate was already known by us was 
used as a standard reference (Figure 2.4.1, Table 2.4.1).
10
 The stock solution of the 
samples was dilute to different concentrations and the absorbance from each of these was 
measured. And then the PL emission against all these concentrations was measured. All 
the data were then being plotted and the gradient was abstained by the computer. These 
data were then compared with the quinine reference so that the quantum yield of the 
samples could be worked out.  
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Figure 2.4  Quantum yield results of Quinine reference
 
Table 2.4.1  Linear line absorbance vs integrated intensity of quinine reference 
Quinine Sulphate in 1N 
H2SO4 (µg/mL) 
Absorbance at 360 nm Integrated intensity 
0.45 0.015890 14860 
0.88 0.027140 24104 
1.36 0.036320 32216 
1.76 0.051120 42939 
2.64 0.060470 50924 
 
One or two drops of Quinine sulphate were added to pre-prepare 0.1M H2SO4 in a cuvette. 
The cuvette was shaken several times and then UV-Vis spectrum was taken over the 
wavelength range between 200-800 nm. CdSe NPs stock solution were diluted with water 
and stored in a 10 ×10 mm quartz cuvette. The diluted solution of CdSe NPs was tested 
using the same process as used for the quinine sulphate reference. The slope from the 
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scatter plot of absorption against integrated intensity was used to calculate the quantum 
yield by using the equation below. 
    (
    
     
)  
  
 
 
 
  
 
In this equation, Q is the quantum yield; ŋ is the refractive index of the solvent. Grad is 
the gradient from the plot of integrated fluorescence intensity and absorbance. The 
subscript R means the reference fluorophore of a known quantum yield.
10
  
2.5 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) is a microscopy technique whereby a beam of 
electrons is transmitted through an extremely thin specimen, interacting with the 
specimen as it passes through. Ernst Abbe originally proposed that the ability to resolve 
detail in an object was limited by the wavelength of the light used.
7
 The first TEM was 
built by Max Knoll and Ernst Ruska in 1931.
7
 
A JOEL 2000EX with the accelerating voltage at 200 kV was used to obtain TEM images. 
The grids used in this study were Agar scientific- S160, carbon film, 200 meshes. 
Initially, the samples were placed in a sonic bath to separate aggregated particles. 
Otherwise, the particles on the film would be too dense and it would be difficult to find 
clear well separated particles. In order to separate these particles completely, an ultrasonic 
time of at least 1 minute was required. After comparison of the dilute samples and the 
stock solutions, it was obvious that the former one gave better images; The Cu thin 
specimen grid was dipped into the CdSe NPs stock solution and the grid was placed on a 
filter paper, and then left for a few seconds; if the concentration was not high enough, 
more samples was dropped on the Cu grid.  
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To get an accurate average particle size more particles were measured from different 
images. Once some particles were found, the final images were adjusted using the 
contrast scale, to highlight the particles and dim the background of the image. In order to 
get a reliable and representative result, at least 100 particles were measured to obtain the 
standard deviation and the average size of the particles. 
2.6 Cell Culture 
The immortalised human hepatocytes (defined as HHL-5) cell line was kindly supplied by 
Dr.Arvind Patel, Medical Research Council (MRC) Virology Unit (Glasgow, UK). 
Human hepatocytes (HHL-5) have the highest capacity for binding hepatitis C virus (HCV), 
Virus-like particles (VLPs) compare to other cell lines such as Huh-7 and HepG2. 
Therefore, this cell line is likely to be very valuable in the viral receptor attachment and 
entry process.
3 
The main reason why we chose HHL-5 was that CdSe NPs can cause liver 
damage. Acute hepatotoxicity involves two pathways, one for the initial injury produced by 
direct effects of cadmium and the other for the subsequent injury produced by 
inflammation. Primary injury appears to be caused by the binding of Cd
2+ 
to sulfhydryl 
groups on critical molecules in mitochondria.
4
 
The HHL-5 cells were routinely cultured in Dulbecco’s modified essential medium 
(DMEM) supplemented with 10 % fetal bovine serum (FBS), 1 % 
Penicillin/Streptomycin (P/S,5000u) and 1 % L-Glutamine(200mM) at 37 ºC in an 
incubator which has humidified atmosphere with 5 % carbon dioxide. Cells (1×10
6
 cells) 
were cultured in the 75 cm
3
 flask. The medium was changed every 2-3 days and checked 
under a microscope to see if the cells achieve 70% -80% confluences.  
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After the cells reached 70% -80% confluences, the old medium was discarded and 
removed by a 10mL pipette. Cells were washed twice by pre-warmed PBS by gently 
pipetting PBS into the flask then carefully mixed by tilting the flask from one side to the 
other twice.  
2mL of pre-warmed Trypsin/EDTA were added to dispatch the cells. Ensuring the film of 
Trypsin/EDTA came into contact with the whole cell surface by tilting the dish twice. 
Excess Trypsin/EDTA was removed using a pipette, and the culturing dish was placed in 
the incubator at 37 ºC for 10 min until the cells detached. The cells were dislodged by 
gently tapping on the side of the flask/dish and were then checked under a microscope. 
Trypsin was deactivated and diluted by the addition of 10 mL of warm fresh DMEM 
medium to the flask. The cells were centrifuged at 1000rpm for 5 min. Gently and 
carefully the supernatant was discarded, and the sedimented cells were mixed in 10 mL of 
pre-warmed DMEM medium. After cell counting under the microscope, the cells were 
diluted to reasonable concentration, for instance, 5000 cells/ well for a 96 well plate. The 
outer wells of the 96 wells plates were filled with 100μL phosphate buffered saline (PBS) 
to limit cell wells from drying out.  
2.7 MTT Cell Proliferation and Viability Assays 
The MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay was 
used to evaluate the cell proliferation and cell viability in the presence of the CdSe NPs. 
MTT assay is a colorimetric assay for measuring the activity of cellular enzymes that 
reduce the tetrazolium dye. Succinate dehydrogenase in the mitochondria of the living 
cells can convert MTT to a water-insoluble crystalline blue violet formazan and deposit 
on the cells, while dead cells cannot perform this process. Dimethyl sulfoxide (DMSO) 
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can dissolve the formazan in the cell; its optical absorption can then be measured by using 
a microplate reader. The number of living cells can be judged by the absorbance value 
(OD value), the larger the OD value is, and the stronger the cell activity will be. 
The immortalised human hepatocytes (defined as HHL-5) cells were seeded in a 96 well 
plate at a concentration of 5.0×10
3
 cells in a final volume of 100 µL /well. The 96 well 
plates were kept in an incubator at 37 ºC and left in a humid atmosphere containing 5 % 
carbon dioxide for 48 hours. Then, the cells were treated with CdSe NPs at various 
concentrations and incubated for a further 24 hours. Next, the medium was removed using 
a pump followed by the washing of cells with PBS. 100µL of 10% solution of MTT 
reagent in media were added to per well of the 96 well plates. This was incubated at 37 ºC 
for 1 hour. The medium was then extracted using a pump and re-suspended of 100µL 
/well of DMSO. To ensure the formazan precipitate was dissolved this mixture was 
pipetted up and down several times for each well. The microplate was read by using 550 
nm as a test wavelength and 630 nm as the reference wavelength. 
 
2.8 Confocal Laser Scanning Microscopy 
The first purely analogue mechanical confocal microscope was designed and produced by 
Eggar and Petran in 1967,
8
 and the first commercial confocal laser scanning florescence 
microscopy systems were produced by Bio-Rad Microscopy Ltd.
8 24 well cell culture 
plate (cat No 662 160) was bought from CELLSTAR®, Greiner bio-one UK. The middle 
square (box) of the standard hemocytometer chamber is 1mm ×1mm. Usually counted 
4-6 box and caculate arverage number which is the cells number per ml. This middle 
square area covered at 100×microscope magnification (10×ocular and 10×objective).11 
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The samples were prepared as follows: cells were cultured on 24 wells plates on slips.   
Firstly, a cover slip was placed in to each well with a tweezers. Then, 70 % ethanol, 300 
µL was added per well. Next, the ethanol was removed and each well was washed with 
PBS twice and left to dry. The cells were cultured on the slips with a density of 2.0×10
5
/ 
well using 500 µL of medium (Figure 2.8.1). 
 
Figure 2.5  24 wells plate plan for confocal microscopy. 
After the cells reached 70 % confluence (In cell culture biology, confluence is the term 
commonly used as a measure of the number of the cells in a cell culture dish or a flask, 
and refers to the coverage of the dish or the flask by the cells) 
8 
usually after cell culture 
for about 2-3 days,
8
 CdSe NPs (10:1) with concentration of 10 µM and15 µM (N10 and 
N15 control means the particles without dialysis, N10 and N15 dialysis means the 
particles were dialysed) were added into the wells (Figure 2.8.1, Figure 2.8.2). The slides 
were collected after 24 hours after the addition of the CdSe NPs the wells (Figure 2.8.2). 
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Figure 2.6 Pick up the slices after 24 hours since the CdSeNPs were added into the cells. 
Before picking up cover slips, each well was washed with PBS twice. Then fixed by 
adding ice-cold methanol, 300 µL per well and waiting for 5 minutes. Subsequently, PBS 
was used to wash each well again, DAPI (concentration with 1:5000) 250 µL per well 
was added and left for 8 minutes. This was washed with PBS twice; the last wash was 
kept in the wells. Slowly and smoothly one slip was picked out and dipped into Milli-Q 
water and then a soft tissue was used wipe off the excess water. 5 µL mounting gel was 
added to the slide and the slip was placed on the slide. The slide was left at room 
temperature for 30 min. Then nail oil was used to fix the slips on to the slide, the slide 
was covered with film paper and stored in 4 ° C refrigerator. Then the images are 
recorded under the confocal microscopy. 
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Chapter 3. Synthesis of CdSe quantum dots and their optical 
properties 
 
3.1 The stability and ageing results of the CdSe NPs 
Most of the papers relating to CdSeNPs have focused on how the band gap, structure or 
optical properties of CdSe/ZnS nanoparticles change through heating CdSe/ZnS 
nanocrystal, coating of CdSe NPs or the dissolution of Cadmium ions in different solvents 
at different temperatures.
1-21
 However, this study focuses on both optical properties and in 
vitro cytotoxicity of CdSe NPs with differing sodium citrate stabiliser concentrations and 
ratios of Cadmium to Selenium. 
Table 3.1.1 The colour and stability of the CdSeNPs. 
 
If the samples stored longer than the days in table 3.1, it will become unstable and have 
sediments. The CdSe NPs (10:1) with 0.2% sodium citrate stabiliser have the most stable 
characteristics (Table 3.1) and deepest colour (Table 3.1). Conversely, CdSe (1:1) with 
0.05% sodium citrate stabilizer were the least stable (Table 3.1). Basically, the 
characteristics of CdSe (10:1) were more stable than CdSe (4:1) while CdSe (4:1) were 
more stable than CdSe NPs (1:1). Among CdSe NPs (10:1), (4:1) and (1:1), those with 0.2% 
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of sodium citrate stabilizer were the most stable. In contrast, the samples with 0.05 % 
sodium citrate as stabilizer were the most unstable (Table 3.1). Therefore, the more 
sodium citrate stabiliser and Cadmium accumulated in the CdSe NPs, the more stable the 
particles.  
Many papers which relates to photoluminescence spectrum of CdSe NPs do not include 
ageing studies.
1-21
 The novelty of this study was to focus on the ageing part of the CdSe 
NPs. CdSe NPs (10:1) with 0.05, 0.1 and 0.2 % sodium citrate, CdSe NPs (4:1) with 0.05, 
0.1 and 0.2 % sodium citrate plus CdSe (1:1) with 0.05, 0.1 and 0.2 % sodium citrate 
were tested on the third day after synthesis (in order to give the particles enough time to 
grow). Each sample was then tested daily to see if the spectrum changed with time.  
3.1.1 CdSe NPs (1:1) with 0.05%, 0.1% and 0.2% sodium citrate as stabilizer 
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Figure 3.1 The ageing spectrum of CdSe NPs (1:1) with 0.05% (A, B), 0.1% (C, D) or 0.2% 
(E, F) sodium citrate stabilizer. 
Graph A,C and E demonstrate the photoluminescence spectrum of CdSe NPs (1:1) with 
0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer, respectively.  The excitation was 460 
nm. Filter cut-off at 515 nm. Graph B, D and F demonstrate the Ultraviolet-visible 
Spectrum of CdSe NPs (1:1) with 0.05% , 0.1% and 0.2% sodium citrate stabilizer, 
respectively. 
The peak of the ultraviolet-visible spectrum of CdSe NPs (1:1) with 0.05 %, 0.1 % and 
0.2 % sodium citrate as stabilizer were all around 625 nm. The peak of the 
photoluminescence spectrum of CdSe NPs (1:1) with 0.05 %, 0.1 % and 0.2 % sodium 
citrate stabilizer were all around 550 nm (Figure 3.1.1). Over the course of a week since 
the samples were synthesised, it is obvious that the luminescence of the sample was very 
C D 
E F 
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stable at least for one month. The fluctuated spectrum of CdSe NPs (1:1) samples 
probably because the evaporation and sample damage during the experiments (Figure 
3.1.1). Nor Aliya Hamizi, et al,
 6
 heated the CdSe QD (1:1) solution at 160 °C and tested 
the PL and UV spectra. The UV-Vis spectrum from this paper was similar to that of the 
CdSe (1:1) particles in this study. 
 
3.1.2 CdSe NPs (4:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer 
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Figure 3.2 The ageing spectrum of CdSe NPs (4:1) with 0.05 % (A, B), 0.1 % (C, D) or 
0.2 % (E, F) sodium citrate stabilizer. 
Graph A, C and E demonstrate the photoluminescence spectrum of CdSe NPs (4:1) with 
0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer, respectively. The excitation was 
345nm. Filter cut-off at 390 nm. Grraph B, D and F demonstrate the Ultraviolet-visible 
Spectrum of CdSe NPs (1:1) with 0.05 % , 0.1 % and 0.2 % sodium citrate stabilizer, 
respectively. 
The peak of the photoluminescence spectrum of CdSe (4:1) NPs with 0.05 %, 0.1 % and 
0.2 % sodium citrate stabiliser were all around 590 nm (Figure 3.1.2). The peak of the 
ultraviolet-visible spectrum of CdSe NPs (4:1) with 0.05 %, 0.1 % and 0.2 % sodium 
citrate stabiliser were all around 550 nm. Over the course of a week since the samples 
were synthesised, it is obvious that the luminescence of the sample didn’t change a lot 
during the first month. Ruosheng, et al,
 14
 synthesised Mn:CdSe nanocrystals at 80 ° C, 
160 ° C, 180 ° C and  200 ° C also got similar PL spectrum results. The trend of the 
spectrum of CdSe NPs (4:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabiliser kept a 
similar curve during the first months since they were synthesised, the fluctuation of the 
samples in the spectrum probably because of the evaporation and sample damage during 
the experiments (Figure 3.1.2).  
E F 
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3.1.3  CdSe NPs (10:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate 
stabilizer 
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Figure 3.3 Graph A, C and E demonstrate the photoluminescence spectrum of CdSe NPs 
(10:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer, respectively. The excitation 
was 345 nm. Filter cut-off at 390 nm. Graph B, D and F  demonstrate the 
A B 
C D 
E F 
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Ultraviolet-visible Spectrum of CdSe NPs (10:1) with 0.05 % , 0.1 % and 0.2 % sodium 
citrate stabilizer, respectively. 
The peak of the photoluminescence spectrum of CdSe NPs (10:1) with 0.05 %, 0.1 % and 
0.2 % sodium citrate stabilizer were all around 590 nm (Figure 3.1.3). The peak of the 
ultraviolet-visible spectrum of CdSe NPs (10:1) with 0.05 %, 0.1 % and 0.2 % were all 
around 550 nm. Xianfeng, et al,
 1
 heated the 2-MSA-CdSe nanoparticles at 100 °C for 102 
hours showing a similar absorption and photoluminescence spectra to this study. 
The ageing results show that the CdSe NPs were roughly stable during the first month. 
Although there were some fluctuations in the graphs it was probably because of sample 
evaporation, or the consumption and damage of the samples during the experiments. The 
most stable sample was the sample with 0.2% sodium citrate and the most unstable was 
the sample with 0.05% sodium citrate (Figure 3.1.1-Figure 3.1.3). Waleed E, et al,
 12
 
synthesised different molar ratios of CdSe:ME in different atmospheres. The particles 
which were synthesised in nitrogen gas had a higher PL intensity value than those without 
nitrogen. Ying W, et al,
 20
 exposed the samples to light in air or in nitrogen and got a 
higher intensity value for the luminescence. However, in this study, all the samples were 
stored in a dark draw and covered with foil to keep out of the light to ensure the samples 
were not affected by any other parameters throughout the aging process. Therefore, all the 
results depict the luminescence of the samples themselves. 
3.2 The size of the CdSe NPs 
3.2.1 Size calculation 
According to the effective mass model
7, 19
 the diameter of the CdSe NPs can be calculated 
by use the formulation below. 
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Equation 3.2.1 
 
r is the radius of the nanoparticles. The second term is the particle-in-a-box confinement 
energy for an electron-hole pair in a spherical quantum dot and the third term is the 
Coulomb attraction between an electron and hole modified by the screening of charges by 
the crystal. After multiplying by r
2
, this can be rearranged, to the quadratic formula 
below. 
                  
Equation 3.2.2 
 
 
Here, Eg = h c / λ, c = 2.998x10
8
 ms
-1
, Band-gap of bulk CdSe: 1.74 eV, Effective masses: 
me
*
 = 0.13 me, mh
*
 = 0.6 me, Plank’s constant: h = 6.63 × 10
-34
 J•s, Electron mass me = 
9.1× 10
-31
 kg, Absorption peak wavelengths were different according to different particles.  
The absorption peak of CdSe NPs (1:1) was at around 550 nm (Figure 3.1.1). The 
Absorption peak of CdSe NPs (4:1) was at about 590 nm (Figure 3.1.2). The Absorption 
peak of CdSe NPs (10:1) with 0.05 % sodium citrate stabilizer was at about 550 nm 
(Figure 3.1.3-A, B), the absorption peak of CdSe NPs (10:1) with 0.1 % sodium citrate as 
stabilizer was at about 575 nm (Figure 3.1.3-C, D) and the absorption peak of CdSe NPs 
(10:1) with 0.2 % sodium citrate stabilizer was at about 590 nm (Figure 3.1.3-E, F). The 
radius times two will be the diameter of the nanoparticles. 
Table 3.2.1  Diameter value of the CdSeNPs in theory 
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Sodium citrate 
(%) 
 
Ratio (Cd:Se) 
0.05 0.1 0.2 
CdSe (10:1) 4.8 5.2 5.6 
CdSe (4:1) 5.6 5.6 5.6 
CdSe (1:1) 4.8 4.8 4.8 
Different size of the particles were synthesised by using of 2 mL of 0.01, 0.04 and 0.1M 
cadmium perchlorate giving ratios of 1:1, 4:1 and 10:1 cadmium to selenium respectively. 
This resulted in average particle sizes of 5.0 nm, 5.8 nm, and 4.9 nm respectively (Table 
3.3). The real size of the CdSe NPs was very close to the theoretical size (Table 3.2) 
which means that the real size of the CdSe NPs in table 3.3 was reliable. The diameters of 
the particles were evaluated using the PL spectra, UV-Vis spectra and were measured 
using transmission electron microscopy (TEM) imaging.  
3.2.2 TEM results of CdSe (10:1) with 0.05 %, 0.1 % and 0.2 % sodium 
citrate as stabilizer 
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Figure 3.2.2 TEM results of CdSe (10:1) with 0.05 % , 0.1 % and 0.2 % sodium citrate as 
stabilizer. 
Picture A, C, E demonstrate the TEM images of CdSe NPs (10:1) with 0.05 %, 0.1 % and 
0.2 % sodium citrate stabilizer, respectively. Picture B, D, F show the size distribution of 
CdSe NPs (10:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer, respectively.  
The average size of CdSe NPs (10:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate 
stabilizer (Figure 3.2.2) was approximately 5.4 ± 1.3, 6.7 ± 1.7 and 7.2 ± 1.6 nm 
respectively. Among the 100 particles measured in each picture, a size of about 6.0, 6.0 
and 7.0 nm were the most frequently observed with 0.05 %, 0.1 % and 0.2 % sodium 
citrate as stabilizer, respectively. The TEM images (Figure 3.2.2) also show that the shape 
of CdSe NPs (10:1) was regular round and separated very well, so they could be easily 
identified and counted. Mojtaba, et al,
 16
 heated the CdSe quantum dots with a microwave 
method to see if the temperature will play an important role in the experiment. After 
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heating the CdSe quantum dots coated with ODPA nanoparticles, the TEM image showed 
a similar result to CdSe NPs (10:1) NPs in this study. Waleed E, et al,
 12
 prepared the 
CdSe quantum dots at different CdSe/Me ratios. A CdSe/Me ratio of 1:3 had a similar 
TEM image to CdSe (10:1) NPs. However, the TEM images of CdSe (10:1) were much 
clearer and shows more regular, round particles. This is probably because the stabilizer 
used and structure of the particles was different. 
3.2.3 TEM results of CdSe (4:1) with 0.05 %, 0.1 % and 0.2 % sodium 
citrate as stabilizer 
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Figure 3.2.3 TEM results of CdSe (4:1) with 0.05 % , 0.1 % and 0.2 % sodium citrate as 
stabilizer. 
Picture A, C, E demonstrate the TEM images of CdSe NPs (4:1) with 0.05 %, 0.1 % and 
0.2 % sodium citrate stabilizer, respectively. Picture B, D, F show the size distribution of 
CdSe NPs (4:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer, respectively. 
The average size of CdSe NPs (4:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate 
stabilizer (Figure 3.2.3) was approximately 6.5 ± 1.9, 8.2 ± 2.4 and 9.3 ± 2.4 nm. Among 
the 100 particles measured in each picture, a size of about 6.0, 8.0 and 9.0 nm were the 
most frequently observed with 0.05 %, 0.1 % and 0.2 % sodium citrate as stabilizer, 
respectively. The TEM image (Figure 3.2.3) also show that the CdSe NPs were round and 
separated very well, so they could be easily identified and counted. CdSe quantum dots 
from different cadmium complexes such as Cd-Lu, Cd-DDPA, Cd-Myr, Cd-St also 
showed similar images; as shown in the paper of Mojtaba,et al.
16
 However, the images in 
this paper were much more dense and clear than CdSe (4:1) NPs. This was probably 
because the former used different cadmium complexes and the latter just uses the pure 
elements, cadmium and selenium. Another reason could be that the atmosphere 
(temperature, ramp, cooling time) was different in these two studies.  
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3.2.4 TEM results of CdSe (1:1) with 0.05 %, 0.1 % and 0.2 % sodium 
citrate as stabilizer 
           
           
           
Figure 3.2.4 TEM results of CdSe (1:1) with 0.05 % , 0.1 % and 0.2 % sodium citrate as 
stabilizer.  
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Picture A, C, E demonstrate the TEM images of CdSe NPs (1:1) with 0.05 %, 0.1 % and 
0.2 % sodium citrate stabilizer, respectively. Picture B, D, F show the size distribution of 
CdSe NPs (1:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer, respectively. 
The average size of CdSe NPs (1:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate 
stabilizer (Figure 3.2.4) was approximately 5.7 ± 1.4, 6.8 ± 2.3 and 8.4 ± 2.3 nm. Among 
the 100 particles measured in each picture, a size of about 5.0, 6.0 and 6.0 nm were the 
most frequently observed with 0.05 %, 0.1 % and 0.2 % sodium citrate as stabilizer, 
respectively. The TEM image (Figure 3.2.4) also shows that the CdSe NPs were irregular 
but separated very well, so they could be easily identified and counted. Heating CdSe 
quantum dots at 170 °C for 50 minutes or use CdSe (ZnS) core (shell) NPs also show 
similar images, which are explained in papers by Rong He, et al,
7
 and Lasantha, et al.
9 
Table 3.2.2 The diameters of CdSe NPs measured by TEM. Mean ± Standard deviation 
(SD), n=100. 
Sodium citrate 
(%) 
 
Ratio (Cd:Se) 
0.05 0.1 0.2 
CdSe (10:1) 5.4 ± 1.3 6.7 ± 1.7 7.2 ± 1.6 
CdSe (4:1) 6.5 ± 1.9 8.2 ± 2.4 9.3 ± 2.4 
CdSe (1:1) 5.7 ± 1.4 6.8 ± 2.3 8.4 ± 2.3 
The theory values (Table 3.2) are within 95 % confidence interval (Mean ± 2SD) of 
measured values (Table 3.3) accordingly. According to the table above (Table 3.3), 
different percentages of sodium citrate result in different particle sizes. CdSe NPs with 
0.2 % sodium citrate stabilizer give the largest particle size in each of three types of CdSe 
NPs (10:1, 4:1 and 1:1) compare to NPs with 0.1 % and 0.05 % stabilizer. Conversely, 
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CdSe NPs with 0.05 % sodium citrate stabilizer has the smallest particle size in each type 
of CdSe NPs. Overall, the more the stabilizer in the particles the larger the particles are.   
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3.3 The Quantum yield of the CdSe NPs 
Quantum yield (QY) means the ratio of photon in a photochemical reaction to the total 
number of absorption photons by the sample. The most reliable method for recording QY 
is the comparative method of Williams et al,
 22 
which involves the use of well 
characterised standard samples with known QY values. This method compares the 
integrated fluorescence intensity and the absorption for unknown sample and standard 
using optical densities between 0.1 and 0.01. Most of papers relating to CdSe and 
quantum yield were use different method.
1, 8, 20, 23-32
 They use different Cd/Se ratio, heat 
the particles to a certain temperature to see if the band gap or change the atmosphere to 
affect the quantum yield.
20
 However, the primary response of interest in the study was the 
fluorescence of the quantum dots caused by different ratio of Cadmium to Selenium and 
different percentage sodium citrate as stabilizer compare with quinine sulphate as 
reference. The reason why choose quinine sulphate as reference is because its absorbance 
range is similar to the CdSe NPs. Furthermore, the entire quantum yield results in this 
study depict the characteristic of the samples themselves without the influence of any 
other parameters.  
 
 
 
 
 
 
 
 
59 
 
3.3.1 CdSe NPs (1:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilize. 
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Figure 3.4 Quantum Yield results of CdSe (1:1) with 0.05 % , 0.1 % and 0.2 % sodium 
citrate stabilizer.  
Graph A, C, E show emission spectra obtained for CdSe NPs (1:1) with 0.05 %, 0.1 %, 
0.2 % sodium citrate stabiliser, respectively. Excitation was 460 nm, filter 515 nm cut off. 
Graph B, D, F demonstrate absorption spectra obtained for CdSe NPs (1:1) with 0.05 %, 
0.1 % and 0.2 % sodium citrate stabiliser. Excitation was 460 nm. Graph G, H, I show 
scatter plot of absorbance at 460 nm against integrated intensity for CdSe NPs (1:1) 
0.05 %, 0.1 %, 0.2 % sodium citrate stabiliser, respectively. The numers from 1-15 was 
different concentrations dilute from each samples.  
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Table 3.3.1 Linear line absorbance vs integrated intensity of CdSe (1:1) with 0.05 %, 0.1 % 
and 0.2 % sodium citrate stabiliser. 
CdSe NPs with 
different percentage 
of sodium citrate 
stabiliser 
Concentrations 
Absorbance at 460 
nm 
Integrated Intensity 
CdSe (1:1) with 
0.05 % sodium 
citrate stabiliser 
1 0.064 196 
2 0.060 180 
3 0.053 161 
4 0.047 142 
5 0.041 120 
CdSe (1:1) with 
0.1 % sodium citrate 
stabiliser 
6 0.078 150 
7 0.048 95 
8 0.037 70 
9 0.027 54 
10 0.022 40 
CdSe (1:1) with 
0.2 % sodium citrate 
stabiliser 
11 0.089 156 
12 0.072 120 
13 0.060 100 
14 0.046 70 
15 0.031 50 
Here, the quantum yield of CdSe NPs was calculated via the following equation:  
    (
    
     
)  
  
 
 
 
  
Where Q is the quantum yield, Grad is the gradient from the plot of integrated 
fluorescence intensity versus absorbance. The subscript R refers to the reference 
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fluoropohore of known quantum yield. Here Quinine Sulphate was used as reference,
 1
 
which has a quantum yield of 54.6% when dissolved in 1N H2SO4. 1N (0.5M) H2SO4 had 
a refractive index of 1.346,
1
 while the refractive index of water was 1.33.
1
 The gradients 
of Quinine sulphate and CdSe NPs (1:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate 
stabilizer were 1901980,
1
 3032 (Table 3.5, Figure 3.3.1- A, B, G), 1936 (Table 3.5, 
Figure 3.3.1-C, D, H) and 1735 (Table 3.5, Figure 3.3.1-E, F, I), respectively. 
Q0.05% = 54.6% (
    
       
) × (
     
      
  =0.1 % 
    Q0.1% = 54.6% (
    
       
) × (
     
      
  =0.05 % 
     Q0.2% = 54.6% (
    
       
) × (
     
      
  =0.05 % 
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3.3.2 CdSe NPs (4:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer 
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Figure 3.5 Quantum Yield results of CdSe (4:1) with 0.05 % , 0.1 % and 0.2 % sodium 
citrate stabilizer.  
Graph A, C, E show emission spectra obtained for CdSe NPs (4:1) with 0.05 %, 0.1 %, 
0.2 % sodium citrate stabiliser, respectively. Excitation was 345 nm, filter 390 nm cut off. 
Graph B, D, F demonstrate absorption spectra obtained for CdSe NPs (4:1) with 0.05 %, 
0.1 % and 0.2 % sodium citrate stabiliser. Excitation was 345 nm. Graph G, H, I show 
scatter plot of absorbance at 345 nm against integrated intensity for CdSe NPs (4:1) 
0.05 %, 0.1 %, 0.2 % sodium citrate stabiliser, respectively. The numers from 1-15 was 
different concentrations dilute from each samples. 
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Table 3.3.2 Linear line absorbance vs integrated intensity of CdSe (4:1) with 0.05 %, 0.1 % 
and 0.2 % sodium citrate stabiliser. 
CdSe NPs with 
different percentage 
of sodium citrate 
stabiliser 
Concentration 
Absorbance at 345 
nm 
Integrated Intensity 
CdSe (4:1) with 
0.05 % sodium 
citrate stabiliser 
1 0.109 2587 
2 0.083 2064 
3 0.053 1327 
4 0.042 1136 
5 0.028 793 
CdSe (4:1) with 
0.1 % sodium citrate 
as stabiliser 
6 0.170 7967 
7 0.080 3500 
8 0.061 2350 
9 0.042 1750 
10 0.023 990 
CdSe (4:1) with 
0.2 % sodium citrate 
stabiliser 
11 0.074 2000 
12 0.067 1760 
13 0.062 1550 
14 0.045 1250 
15 0.028 750 
Here, the quantum yield of CdSe NPs was calculated via the following equation:  
    (
    
     
)  
  
 
 
 
  
Where Q is the quantum yield, Grad is the gradient from the plot of integrated 
fluorescence intensity versus absorbance. The subscript R refers to the reference 
66 
 
fluoropohore of known quantum yield. Here Quinine Sulphate was used as reference,
 1
 
which has a quantum yield of 54.6 %
1
 when dissolved in 1N H2SO4. 1N (0.5M) H2SO4 
had a refractive index of 1.346,
1
 while the refractive index of water was 1.33.
1
 The 
gradients of Quinine sulphate and CdSe NPs (1:1) with 0.05 %, 0.1 % and 0.2 % sodium 
citrate stabilizer were 1901980,
1
 3032 (Table 3.6, Figure 3.3.2- A, B, G), 1936 (Table 3.6, 
Figure 3.3.2-C, D, H) and 1735 (Table 3.6, Figure 3.3.2-E, F, I), respectively. 
 Q0.05% = 54.6% (
     
       
) × (
    ²
     ²
  =0.6 % 
 Q0.1% = 54.6% (
     
       
) × (
    ²
     ²
  = 1.3 % 
Q0.2% = 54.6% (
     
       
) × (
    ²
     ²
  = 0.7 % 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
3.3.3 CdSe NPs (10:1) with 0.05 %, 0.1 % and 0.2 % sodium citrate stabilizer 
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Figure 3.6 Quantum Yield results of CdSe (10:1) with 0.05 % , 0.1 % and 0.2 % sodium 
citrate stabilizer.  
Graph A, C, E show emission spectra obtained for CdSe NPs (4:1) with 0.05 %, 0.1 %, 
0.2 % sodium citrate stabiliser, respectively. Excitation was 345 nm, filter 390 nm cut off. 
Graph B, D, F demonstrate absorption spectra obtained for CdSe NPs (4:1) with 0.05 %, 
0.1 % and 0.2 % sodium citrate stabiliser. Excitation was 345 nm. Graph G, H, I show 
scatter plot of absorbance at 345 nm against integrated intensity for CdSe NPs (4:1) 
0.05 %, 0.1 %, 0.2 % sodium citrate stabiliser, respectively. The numers from 1-15 was 
different concentration dilute from each samples.   
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Table 3.3.3 Linear line absorbance vs integrated intensity of CdSe (10:1) with 0.05%, 0.1% 
and 0.2% sodium citrate stabiliser. 
CdSe NPs with 
different percentage 
of sodium citrate 
stabiliser 
Concentrations 
Absorbance at 345 
nm 
Integrated Intensity 
CdSe (10:1) with 
0.05 % sodium 
citrate stabiliser 
1 0.084 18131 
2 0.070 15000 
3 0.064 13000 
4 0.048 10000 
5 0.045 9000 
CdSe (10:1) with 
0.1 % sodium citrate 
stabiliser 
6 0.082 8370 
7 0.066 6200 
8 0.063 6100 
9 0.048 4200 
10 0.046 4100 
CdSe (10:1) with 
0.2 % sodium citrate 
stabiliser 
11 0.101 2348 
12 0.084 1900 
13 0.081 1800 
14 0.064 1400 
15 0.043 800 
Here, the quantum yield of CdSe NPs was calculated via the following equation:  
    (
    
     
)  
  
 
 
 
  
Where Q is the quantum yield, Grad is the gradient from the plot of integrated 
fluorescence intensity versus absorbance. The subscript R refers to the reference 
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fluoropohore of known quantum yield. Here Quinine Sulphate was used as reference,
 1
 
which has a quantum yield of 54.6% 
1
when dissolved in 1N H2SO4. 1N (0.5M) H2SO4 
had a refractive index of 1.346,
1
 while the refractive index of water was 1.33.
1
 The 
gradients of Quinine sulphate and CdSe NPs (10:1) with 0.05%, 0.1% and 0.2% sodium 
citrate stabilizer were 1901980,
1
 214523 (Table 3.7, Figure 3.3.3- A, B, G), 100231 
(Table 3.7, Figure 3.3.3-C, D, H) and 23392 (Table 3.7, Figure 3.3.3-E, F, I), 
respectively. 
     Q0.05% = 54.6% (
      
       
) × (
    ²
     ²
  = 6 %    
     Q0.1% = 54.6% (
      
       
) × (
    ²
     ²
  = 3 % 
       Q0.2% = 54.6% (
     
       
) × (
    ²
     ²
  =0.7 % 
 
Table 3.3.4 The summary of quantum yield rate of CdSeNPs. 
Sodium citrate 
(%) 
 
Ratio (Cd:Se) 
0.05 0.1 0.2 
CdSe (10:1) 6 3 0.7 
CdSe (4:1) 0.6 1.3 0.7 
CdSe (1:1) 0.1 0.05 0.05 
In conclusion, the luminescence of all CdSe NPs in this study was not as strong as 
expected. One reason is because luminescence of the sample itself was not strong when 
compared to other nanoparticles.
1
 Another reason for this could be that some published 
experiments
20
 exposed the samples to light in air or in nitrogen to get a quantum yield. But 
in this study, the results were reflected the nature of the samples without being affected by 
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other factors such as the light or heating. Therefore the values of the quantum yield of the 
samples were lower than other papers.    
Basically, the CdSe NPs (10:1) has the strongest luminescent to particles with other ratios 
of cadmium to selenium (Table 3.7, Figure 3.3.3). In particular, CdSe NPs (10:1) with 
0.05 % sodium citrate has the strongest luminescence (Table 3.7, Figure 3.3.3-A, B, G). 
Conversely, CdSe NPs (1:1) especially CdSe NPs (1:1) with 0.1 % and 0.2 % sodium 
citrate stabiliser has the lowest luminescence (Table 3.5, Figure 3.3.1). 
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Chapter 4. Cytotoxicity and Imaging in cells 
4.1 Cytotoxicity in the immortalised human hepatocytes (HHL-5) cells 
Based on some studies which relates to the toxicity of CdSe NPs,
1-5
 it can be indicates 
that the cytotoxic effect of CdSe NPs were determined by MTT (3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay. Therefore, the study use 
MTT assay to test the cytotoxicity in HHL-5 cells. Because the CdSe NPs with 0.05 % 
sodium citrate in all three kinds of particles show unstable characteristics compared with 
those synthesised with 0.1 % and 0.2 % sodium citrate (Chapter 3), we only choose to 
compare the toxicity of CdSe NPs prepared with 0.1 % and 0.2 % stabiliser in HHL-5 cells.  
4.1.1 CdSe NPs (10:1) with 0.1 % and 0.2 % sodium citrate stabiliser 
     
Figure 4.1 The effect of CdSe NPs on proliferation of HHL-5 cells. 
HHL-5 cells in 96 well plates are treated with CdSe NPs (10:1) with 0.1 % (A) and 0.2 % 
(B) stabilizer of different concentrations (5, 10, 15, 20, 25 and 30 µM). Symbol * 
indicates a statistical significant difference compared with the media only control (0 µM) 
(
* 
P<0.05) 
The label with 0 in Figure 4.1.1 means the media only control. The cells which are treated 
with CdSe NPs show decreasing viability with an increasing concentration of particles 
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(Figure 4.1.1). The two bar charts above both show a dramatic decrease in cell viability 
(from 100 % to 40 %) when the cells are treated with 20 µM of CdSe NPs (Figure 4.1.1). 
When the particle concentration is increase, the observed toxicity to the cells is also 
increase. When the highest concentration (30 µM) of CdSe NPs is add into the HHL-5 
cells, the cell viability rate drop to approximately 9%, the lowest amongst all the 
concentrations test (Figure 4.1.1). When the particle concentration is increase, the observe 
toxicity to the cells is also increase (Figure 4.1.1).   
The half maximal inhibitory concentration is the half maximal (50 %) inhibitory 
concentration (IC) of a substance (50 % IC, or IC50). IC50 also means the concentration 
of a drug that is required for 50 % inhibition in vitro. The IC50 values of CdSe (10:1) 
with 0.1 % and 0.2 % sodium citrate stabilizer are 39.1 µM and 22.2µM, respectively. So 
it indicates that the CdSe NPs (10:1) with 0.2 % sodium citrate has more toxicity than 0.1 % 
in HHL-5 cells. The two graphs also suggest that the higher concentration of the CdSe 
NPs inject into the cells the lower the cell viability rate is.  
Based on the results in Figure 4.1.1, most cells died when increasing the concentration to 
25 and 30 µM, so concentrations of 5, 10, 15, 20 µM are choose to test cell viability in the 
rest of MTT experiments. In order to achieve the same toxicity by the same amount of 
Cadmium, to make sure each MTT results can be compared easily, concentration of 
Cadmium (CdSe (4:1)) is increased to 2.5 times higher than CdSe (10:1) (Figure 4.1.1), 
which are 12.5, 25, 37.5, 50 µM respectively (Figure 4.1.2). In Figure 4.1.3, Cadmium 
concentration (CdSe (1:1)) is increase to 10 times higher than CdSe (10:1) (Figure 4.1.1), 
which are 50, 100, 150 and 200µM, respectively. 
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4.1.2 CdSe NPs (4:1) with 0.1 % and 0.2 % sodium citrate stabilizer 
 
Figure 4.2 The effect of CdSe NPs on proliferation of HHL-5 cells. 
HHL-5 cells in 96 well plates are treated with CdSe NPs (4:1) with 0.1 % (A) and 0.2 % 
(B) stabilizer of different concentrations (12.5, 25, 37.5 and 50 µM). Symbol * indicates a 
statistical significant difference compared with the media only control (0 µM) (
* 
P<0.05) 
The label with 0 in Figure 4.1.2 means the media only control. HHL-5 cells which are 
treated with CdSe NPs show decreasing viability with an increasing concentration of 
particles (Figure 4.1.2). These two bar charts above show a gradual decrease in cell 
viability (from 100 % to 80 %) when the cells are treated with 12.5 µM of CdSe NPs 
(Figure 4.1.2). When the highest concentration (50 µM) of CdSe NPs is added into the 
HHL-5 cells, the cell viability rate drop to approximately 30 % (Figure 4.1.2 A) and 18 % 
(Figure 4.1.2 B) which are the lowest amongst all the concentrations test in each graph, 
respectively. Therefore, the higher concentration of CdSe NPs inject into the cells, the 
lower cell viability was recorded. (Figure 4.1.2). The IC 50 values of CdSe (4:1) with 0.1 % 
and 0.2 % sodium citrate stabilizer are 39.7 µM and 35 µM, respectively. 
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4.1.3 CdSe NPs (1:1) with 0.1 % and 0.2% sodium citrate stabilizer 
  
Figure 4.3 The effect of CdSe NPs on proliferation of HHL-5 cells. 
The white bar shows HH-L5 cells in 96 well plates treated with 0.1 % (A) and 0.2 % (B) 
sodium citrate as a control. The grey bar shows the HHL-5 cells in 96 well plates which 
are treated by different concentrations (50, 100, 150 and 200µM) of CdSe NPs (1:1) with 
0.1 % (A) and 0.2 % (B) sodium citrate. Symbol * indicates a statistical significant 
difference compared with the media only control (0 µM) (
*
P<0.05).  
The label with 0 in Figure 4.1.3 means the media only control. The rest of the control in 
Figure 4.1.3 is different ratio of sodium citrate which matches to each concentration of 
CdSe NPs. The cells which are treated with CdSe NPs show decreasing viability with an 
increasing particle concentration (Figure 4.1.3). Figure 4.1.3 A shows a gradual decrease 
in cell viability (from 100 % to 80 %) when the cells are treated with 100 µM of CdSe 
NPs. Figure 4.1.3 B shows a gradual decrease in cell viability (from 85 % to 75 %) when 
the cells are treated with 100 µM of CdSe NPs. When the highest concentration (200 µM) 
of CdSe NPs is added into HHL-5 cells, the cell viability rate drop to approximately 65 % 
(Figure 4.1.3 A) and 60 % (Figure 4.1.3 B) respectively, which are the lowest amongst all 
the concentrations test in each graph. Therefore, the higher the concentration of the CdSe 
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NPs injected into the cells, the lower cell viability is recorded. The IC 50 value of CdSe 
(1:1) with 0.1 % (Figure 4.1.3 A) and 0.2 % (Figure 4.1.3 B) sodium citrate stabiliser are 
281.5 µM and 360.7 µM, respectively. When the concentration of the particles is 
increased, the toxicity observed in the cells increase according (Figure 4.1.3).   
Overall, if calculating the concentration of CdSe NPs by Selenium, the total concentration 
of CdSe pairs in each preparation (400 µM) was determined based on the assumption that 
all of the Se
2-
 in the C3H8N2Se reacted to form CdSe pairs. If Cadmium was used to 
calculate the concentration, the toxicity in HHL-5 cells from  high to low is CdSe (10:1) > 
CdSe (4:1) > CdSe (1:1) (Figure 4.1.1-4.1.3), and the toxicity of the particles with 
different sodium citrate concentrations from high to low was 0.2% > 0.1%. In order to 
compare each ratio (Cd to Se) with the same concentration, concentration of CdSe (4:1) 
was 2.5 times higher than CdSe (10:1) (Figure 4.1.1 and 4.1.2) and concentration of CdSe 
(1:1) was 10 times higher than CdSe (10:1) (Figure 4.1.3 and 4.1.2). 
 
4.2 Confocal Imaging results in MCF-7 cells 
There are many studies focus on the confocal images of different chemical structures of 
CdSe NPs and captured numerous useful images which proved that the CdSe NPs has 
great potential in biology application area.
6-9
 In this study, CdSe NPs (10:1) with 0.1 % 
sodium citrate stabilizer have a photoluminescence in the orange-red range (about 590 nm, 
Figure 3.1.3-C, D) which is useful for biological imaging. Therefore, this kind of particle 
has been used in the experiment. In order to study their potential for bioimaging, MCF-7 
cells have been stained with CdSe (10:1) with 0.1 % sodium citrate stabilizer 
nanoparticles.  
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Simultaneous double channel detection (multi-track) was set as a combination of tunnel 
one and two.
10
 The Argon laser was set as 488 nm to detect the cells (tunnel one, Figure 
4.2.1-4.2.5 b).
10
 The Dapi excitation was set as 325 nm (tunnel two, Figure 4.2.1-4.2.5 
a).
10
 Figure 4.2.1-4.2.5 c was an overlap images of a and b.
10
 Then scan the samples under 
microscopy, capture the images and save images.
10 
4.2.1 Confocal imaging of MCF-7 cells with medium control. 
 
Figure 4.4 Confocal Image of MCF-7 cells with medium control only. 
Fluorescent microscopy image of MCF-7 cells labeled with  a) DAPI, b) nanoparticles, c) 
an overlap image of a) and b). 
Figure 4.2.1 shows the confocal microscope image from the control of medium only.  
The cells were very bright and clearly without any noise or nanoparticle spots in that 
background. Therefore, the image can be used as the control image to compare with the 
cells in different concentration of CdSe NPs below.   
a) b)
c)
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4.2.2 Confocal imaging of MCF-7 cells in CdSe (10:1) with 0.1 % sodium 
citrate as stabilizer with concentration of 10 µM without dialysis 
 
Figure 4.5  Confocal Image of MCF-7 cells after exposure in 10 µM CdSeNPs . 
Fluorescent microscopy image of MCF-7 cells labeled with  a) DAPI, b) nanoparticles, c) 
an overlap image of a) and b). 
Figure 4.2.2 a) shows the MCF-7 cells with DAPI only. The shape of each MCF-7 cells 
can be seen clearly and the cells are bright and well separated. Figure 4.2.2 b) shows the 
trend and distribution of the CdSe NPs. Figure 4.2.2 c) shows the MCF-7 cells stained 
with Cde NPs (10μm) before dialysis, it is obvious that the CdSe NPs (with orange-red 
photoluminescence) have surrounded and covered each live cell. Conversely, the 
background is clear without any particles.  
 
 
a) b)
10 μm 10 μm
10 μm
c)
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4.2.3 Confocal imaging of MCF-7 cells in CdSe (10:1) with 0.1 % sodium 
citrate as stabilizer with concentration of 10 µM after dialysis 
 
Figure 4.6 Confocal Image of MCF-7 cells after exposure in 10 µM CdSeNPs (after 
dialysis) . 
Fluorescent microscopy image of MCF-7 cells labeled with  a) DAPI, b) nanoparticles, c) 
an overlap image of a) and b). 
Figure 4.2.3 a) shows the MCF-7 cells with DAPI only. The shape of each MCF-7 cells 
can be seen clearly and the cells are bright and well separated. Figure 4.2.3 b) shows the 
trend and distribution of the CdSe NPs. Figure 4.2.3c) shows the MCF-7 cells stained 
with CdSe NPs (10μm) after dialysis, it was obvious that the CdSe NPs (which 
photoluminescence was orange-red) surrounded and covered each live cells. Conversely, 
the background was clear and without any particles. Compared to the same concentration 
of CdSe NPs without dialysis (Figure 4.2.2), it seems like there is no big difference 
between them.  
a) b)
c)
10 μm
10 μm 10 μm
84 
 
4.2.4 Confocal imaging of MCF-7 cells in CdSe (10:1) with 0.1 % sodium 
citrate as stabilizer with concentration of 15 µM before dialysis 
 
Figure 4.7 Confocal Image of MCF-7 cells after exposure in 15 µM CdSNPs (before 
dialysis) . 
Fluorescent microscopy image of MCF-7 cells labeled with  a) DAPI, b) nanoparticles, c) 
an overlap image of a) and b). 
Figure 4.2.4 a) shows the MCF-7 cells with DAPI only. The shape of each MCF-7 cells 
can be seen clearly and the cells are bright and well separated. Figure 4.2.4 b) shows the 
trend and distribution of the CdSe NPs. Figure 4.2.4 c) shows the MCF-7 cells stained 
with CdSe NPs before dialysis, it is obvious that the CdSe NPs (with orange-red 
photoluminescence) have surrounded and covered each live cell. Conversely, the 
background is clear, without any particles.  
 
a) b)
c)
15 μm
15 μm
15 μm
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4.2.5 Confocal imaging of MCF-7 cells in CdSe (10:1) with 0.1 % sodium 
citrate as stabilizer with concentration of 15 µM after dialysis 
 
Figure 4.8 Confocal Image of MCF-7 cells after exposure in 15 µM CdSeNPs (after 
dialysis) . 
Fluorescent microscopy image of MCF-7 cells labeled with. a) DAPI, b) nanoparticles, c) 
an overlap image of a) and b). 
Figure 4.2.5 a) shows the MCF-7 cells with DAPI only. The shape of each MCF-7 cells 
can be seen clearly and the cells are bright and well separated. Figure 4.2.5 b) shows the 
trend and distribution of the CdSe NPs. Figure 4.2.5 c) shows the MCF-7 cells stained 
with CdSe NPs after dialysis, it was obvious that the CdSe NPs (with orange-red 
photoluminescence) have surrounded and covered each live cell. Conversely, the 
background was clear and without any particles. Compared to the same concentration of 
CdSe NPs before dialysis (Figure 4.2.4), it seems like that is no big difference between 
them.  
a) b)
c)
15 μm 15 μm
15 μm
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At first, we tried to test the confocal image with the same method and the same 
concentration of CdSe NPs in HHL-5 cells, but the results were not very good because the 
control background was filled with red spots of noise. If the control image was not clear, 
it would be difficult to distinguish which spots were noises and which spots were the real 
CdSe NPs. Therefore, in this study, we choose another cell line which was MCF-7. 
According to the results above (Figure 4.2.1-4.2.5), it is obvious that the MCF-7 cell line 
had a better results than HHL-5 cell line. The control image of MCF-7 was clear and 
without any background noise (Figure 4.2.1). Moreover the cellular toxicity observed in 
MCF-7 is lower for cells with 10 µM of CdSe NPs compared to those with 15 µM CdSe 
NPs. So it can be deduced that the higher the concentrations of CdSe NPs, the more 
nanoparticles the cells will take up.  
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Chapter 5. Summary and future work 
5.1 Summary 
The properties and applications of different kinds of CdSe NPs have been observed in 
many studies. Due to different methods used to synthesize CdSe NPs, each type of CdSe 
NPs has their own special characteristics.
1-3
 Some of them have a special chemical shell 
coating,
 4
 and some of them depend on the changing of synthesis parameters such as 
temperature.
5
  
Some research focus on the ZnS or other chemical coatings with CdSe NPs,
 4
 other 
studies focus on the properties of CdSe NPs by changing the parameters of the NPs such 
as heating temperature and exposure to light.
6 However, this study focused on natural 
properties (without any other parameters affect) of the CdSe NPs with different ratios of 
Cd to Se. In addition, each ratio was divided into three conditions with different 
percentage of sodium citrate as a stabiliser, in order to test optical stabilities and 
biological characteristics of them which have seldom been done before.  
This study uses a convenient and quick wet chemical method to synthesis CdSe NPs.
7-9
 It 
focuses on the toxicity of Cadmium and different ratios of sodium citrate as a stabilizer in 
CdSe NPs which has seldom been discussed before. The important optical and biological 
properties of CdSe NPs which were examined in this thesis are summarized as below: 
Optical properties which include Aging, TEM, and Quantum yield experiments. 
Aging results: Generally speaking, all the particles were very stable (Chapter 3) 
Specifically, stability of CdSe NPs are increasing and colour is changing from deepest to 
pastel along with increased Cd to Se ratio (1:1 < 4:1 < 10:1). In the same ratio such as 
CdSe (10:1), the stability of CdSe NPs increase with elevated concentrations of sodium 
89 
 
citrate (0.05 % < 0.1 % < 0.2 %) (Chapter 3). Therefore, the more sodium citrate 
stabiliser or Cadmium accumulated in the CdSe NPs, the more stable the particles are. 
Based on the stability of photoluminescence (PL) in the CdSe NPs, it can link up with 
chitosan using covalent bond steadily and kept a good fluorescence
11
 in drug delivery. 
Meanwhile, the nanoparticle has highly possible to apply in LED development in the 
future.
10
 
TEM results: Although the size of CdSe NPs have some fluctuation between the 
theoretical and the real one, the average size of CdSe NPs with (10:1), (4:1) sodium 
citrate stabiliser is roughly the same and is bigger than the CdSe NPs with (1:1). The 
different size among theoretical and the real values probably because the different kinds 
of measurement methods between TEM and Aging, one element which could affect these 
results is the state of the samples (TEM samples are solid and aging samples are aqueous 
solution). Different size and shapes of CdSe NPs have their unique potential which 
probably could be used in drug delivery.
11
 
Quantum yield results: The quantum yield rates enhance along with increase Cd to Se 
ratio (1:1 < 4:1 < 10:1). In conclusion, the luminescence of all CdSe NPs in this study was 
not as strong as expected. One reason for this is because luminescence of the sample itself 
was not strong when compared to other nanoparticles.
12
 The other reason could be that 
some published experiments
6
 exposed the samples to light in air or in nitrogen to get a 
quantum yield. But in this study, the results reflect the nature of the samples without being 
affected by other factors such as light or heating. Therefore the values of the quantum yield 
rates of the samples were lower than other papers.
13
 Based on this property, these CdSe 
NPs can be used as a unique and new type of biomaterial for bioimaging and other 
biomedical applications.
14
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Biology properties verify through MTT assay and confocal experiment. 
MTT results: Cadmium is used to calculate the concentration, the toxicity in HHL-5 cells 
from  high to low is CdSe (10:1) > CdSe (4:1) > CdSe (1:1) (Figure 4.1.1-4.1.3), and the 
toxicity of the particles with different sodium citrate concentrations from high to low was 
0.2% > 0.1%. MTT assay has shown that CdSe NPs has high biocompatibility and low 
toxicity in vitro which can apply in biological applications and UV therapy 
application.
15-17
 
Confocal results: The cellular toxicity observed in MCF-7 is lower for cells with 10 µM 
of CdSe NPs compared to those with 15 µM CdSe NPs, and there is no significant 
difference between or after dialysis. The cell viability results and Confocal images both 
indicated that the increase the concentration of the CdSe NPs in the cells, the greater the 
toxicity the cells obtained. This character of CdSe NPs can applied in biomedical area 
such as anti-cancer therapy,
18
 cell targeting
19
 and gene delivery.
20
  
Overall, the stability of CdSe NPs in both optical and biological properties can be applied 
in many areas such as it can provide power for solar cells
21 
and light-emitting diode (LED) 
equipment.
10
 It can also use as an effective drug delivery method.
20
 In particular, it is an 
approach for cancer management which having the potential to inhibit the growth of the 
tumour cells.
21
 With the use of CdSe NPs, it is hoped that perceived toxicity concerns 
associated with prolonged use of anti-cancer agents can be minimized and that their 
bioavailability will be enhanced effectively.
21
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5.2 Future work 
This study demonstrated the CdSe NPs in both optical and biological properties. In 
particular, the stable photoluminescence and low toxicity of CdSe NPs which could be 
applied in drug delivery in the future.
20
 In addition to our study, a limited number of 
studies from other laboratories have also evaluated the useful of CdSe NPs which has 
similar properties but different chemical structures compare to this study.
21-43
  
However, there are still many properties of CdSe NPs which have not been discovered 
due to short of time. For instance, the optical properties of CdSe NPs could be dig out 
further, some studies indicate that there is a potential of CdSe NPs to use in UV therapy,
17
 
if further research could be done, it will provide a new and energy saved method in 
clinical therapy. Moreover, based on the strong luminescence and good stability 
properties of CdSe NPs, the particle itself could be highly possible applied in power 
source provided, such as in solar cells
21
 and LED areas.
10
 For example, use 
semiconductor nanoparticle light source give benefits to LED source in many parts such 
as lower energy consumption, longer lifetime, improved physical robustness, smaller size, 
and faster switching.
44
 
One of the potential applications of CdSe NPs in biomedicine is drug delivery.
19, 21
 Based 
on the IC 50 values in MTT assay in this study, further research could test a concentration 
which has lowest toxicity and highest luminescence of CdSe NPs, so that the toxicity can 
be under control and the CdSe NPs can be traced as well. Moreover, due to the 
luminescence of CdSe NPs, when it encapsulated anti-cancer medicine and adheres to the 
target tumour cells, the whole process could be observed, record and controlled as well. 
Therefore, it could provide an effective and convenient way to cure cancer.
20-21
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